Randomized, Placebo-Controlled Study of Leptin for the Treatment of HIV Lipodystrophy and Metabolic Syndrome

NCT00140244 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

HAART-induced Lipodystrophy and Metabolic Syndrome

Interventions

DRUG: r-metHuLeptin
DRUG: Placebo

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

[object Object]
[object Object]